$BHR

Al Shams Investments Responds to Braemar's Appointment of Another Conflicted Ashford Inc. Executive to the Board of Directors

Al Shams Investments, the largest shareholder of Braemar Hotels & Resorts (NYSE: BHR), sent a June 2 letter to Braemar’s outside directors urging them to call the 2026 annual meeting so shareholders can elect new directors. Al Shams said two outside directors resigned and the board appointed another Ashford Inc. executive, increasing Ashford-related seats to over 40%, and warned strategic transactions could pay Ashford more than $480 million.

Original reporting
Published Jun 2, 2026, 6:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 7:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$BHR
Bearish
medium confidence
Mentioned
$BHR
Relevance
8/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$BHRBearishMed
01

Why it matters

This is an activist/governance escalation that can trigger a proxy contest, delay or reshape strategic transactions, and increase perceived risk of related-party decision-making.

02

Market read

Governance and related-party conflict concerns are being escalated by the largest shareholder, increasing uncertainty around board control and any strategic transactions involving the external advisor.

03

What to watch

The letter does not confirm any specific transaction terms or timing; market reaction may depend on whether Braemar responds with concrete governance steps, proxy timelines, or disclosures about the alleged $480M payment.

Relevance 8/10Novelty 4/10Timing: Ahead of the 2026 annual meeting and amid an ongoing board/activist dispute.

Background

Al Shams says it previously urged Braemar to pause hotel divestitures pending board reconstitution, and now escalates by demanding the 2026 annual meeting be called after two outside directors resigned and were replaced with Ashford executives.

Company-level read

Ticker impact

$BHRBearishMedium confidence
Context

Al Shams, BHR’s largest shareholder, urges Braemar’s outside directors to call the 2026 annual meeting and replace board members, citing Ashford-related conflicts and potential $480M payments.

Expected impact

Near-term volatility risk for BHR as investors price higher probability of proxy contest and delays/changes to strategic actions.

Evidence & confidence

The article is a fresh escalation by the largest shareholder, explicitly targeting board composition and timing of the annual meeting; it also flags a large potential payment tied to strategic transactions, which can affect deal economics and investor sentiment.

Market effects

Highlights governance and related-party conflict risks common in hotel REIT/asset-light hospitality models using external advisors.

Primarily US-listed governance/activist dynamics; limited direct regional spillover implied.

Could influence investor perception of external-advisor structures in cross-border hospitality investments, but impact is mostly company-specific.

Counterpoint

Braemar may argue board refreshment is routine and that Ashford involvement is operationally necessary, with conflicts managed through committees and process rather than requiring immediate director turnover.

Key entities

  • Braemar Hotels & Resorts Inc.

    US-listed hotel/resort company whose outside directors are being urged to call the 2026 annual meeting and address alleged advisor conflicts.

  • Al Shams Investments Limited

    Largest shareholder of Braemar; issuing open letters and pushing for board changes and shareholder election of new directors.

  • Ashford, Inc.

    External advisor whose executives (per the letter) are said to occupy >40% of board seats after director resignations.

  • Archie and Monty Bennett

    Named by Al Shams as controlling shareholders of Ashford, alleged to drive conflicts in Braemar’s strategic review.

Related articles

$BHRMed

Braemar Hotels & Resorts Inc. (BHR): Results of Operations and Financial Condition

Braemar Hotels & Resorts Inc. (BHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bhr2026q2earningsrelease.htm EX-99.1 Document EXHIBIT 99.1 NEWS RELEASE Contact: Justin Coe Joe Calabrese Chief Accounting Officer Financial Relations Board (972) 490-9600 (212) 827-3772 BRAEMAR HOTELS & RESORTS REPORTS SECOND QUARTER 2026 RESULTS DALLAS – August 5, 202

$BHRMed

Braemar Hotels & Resorts Inc. (BHR): Completion of Acquisition or Disposition of Assets

Braemar Hotels & Resorts Inc. (BHR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 bhr3packdispoproforma-ex991.htm EX-99.1 Document EXHIBIT 99.1 On July 14, 2026, Braemar Hotels & Resorts Inc. (“Braemar” or the “Company”) completed the sale of: (i) The Ritz-Carlton Sarasota located in Sarasota, Florida (“The Ritz-Carlton Sarasota”); (ii) Hotel Yountvi

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.

$DVAMed

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita HealthCare Partners (NYSE:DVA) rose about 2.1% premarket after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and long-term growth. The upgrade followed DaVita’s Q2 2026 results: adjusted EPS $4.02 vs $3.92 expected, revenue about $3.55B vs estimates, while guidance stayed unchanged.